OBLN..4.22 Obalon Therapeutics..Medical Tech Company working to develope its gas-filled intragastric balloon system. This is the first and only FDA-approved product to treat obese patients. Looking to merge with ReShape Lifesciences VERY LOW FLOAt 7.77 million
LODE..3.50..Comstock Mining Extracting and producing a large quantity of renewable natural resources. Acquired majority stake lithium-ion battery recycling company Considered Undervalued Float 37 million 59% Return On Equity During quarter increased net income to 7.9 million Assets 70 million 63% year over year growth TipRanks Moderate buy Target Price 9.25
TLSA..2.51..Tiziana Life Sciences Just announced Initiation Of Clinical Trial In A Secondary Progressive Multiple Sclerosis Patient With Nasal Spray Foralumab.
Raised To Buy FTCI..9.39..FTC Solar Global Provider Of Advanced Solar Tracking Systems Revenue has grown faster 253% the US Market Average of 17% Return On Equity 1,300% VERY LOW FLOAT 8.21 million StockTA Very Bullish Long TipRanks Strong Buy With Target Price 12.83
Up 32% pre-market Buy and Hold USWS..1.26..US Well Services Announced move towards Full Electricfication Of Portfolio All-electric hydraulic fracturing services provider and expects to have fully exited the diesel frac market by end of !4 2021 Will become first publicly-traded pure-play electric completion services provider
From Sell To Buy? DPW..Up 18% pre-market..2.78 Diversified Holding Company Earnings Report Q1 2021 Revenue of 13.2 million Up 136% from Prior Year's Quarter Q1 2021 Net Income of 2 million Compared to 6.5 million Loss in Prior Year's Quarter. Considered Undervalued Revenue has grown faster 33% than US Market Average of 1% Float 49 million A Walletinvestor Buy and Hold..Patience as stability will lead to a five year forecast of 8.10
Buy and Hold CAMT..35.35..Camtek Israeli maker of electronic inspection and metrology measuring devices given a 91 Relative Strength Rating..The new score tells you Company is now outperforming 96% of all stocks in Fundamentals and Technicals. Posted 267% EPS Growth Posted Acceleration Growth Last Four Reports Holds Number 1 Rank Among Electronic Scientific Measuring Industry Group Still Considered Undervalued Ernings To Grow 66% Per year Forecast To Grow 35% Per year Very Low Float 26 million TipRanks Strong Buy With Target Price 40.00
A Future I Told You So UCLE..4956..US Nuclear Corp VERY Lpw Daily Volume Average 45K..Not for long Future Star US Nuclear and Grapheton's New SuperCapacitors Could Charge Your Next Electric Vehicle In Seconds.
PHRRF...321..Pharmather Holdings Filed For FDA Orphan Drug Designation For Ketamine To Treat Lou Gehrig's Disease..ALS
ITRN..24.24 Provider of location-based services Q1 Just Beat Estimates and Revenue Considered Undervalued Return On Equity to be high in 2 years 34% Earnings Forecast To Grow 103% per year Float 14 million StockTA Bullish Short and Long Barchart Strong Buy TipRanks Moderate Buy with Target Price 26.00...caveat being PT out before latest Earnings from Q1
TIGR..19.28..UP Fintech Client Online Brokerage Firm Focusing On chineseInvestors Just Hit Record High Q1 2021 Added 296K new client accounts in first quarter of 2021 more than 3 times that of first quarter in 2020 Total Client Account Balance reached Record High 21.4 billion in Q1Revenue increase 255% year over year to 81.3 million Revenue grown faster 120% than US Capital Market Average of 18% Float 57 million Barchart Buy TipRanks Moderate Buy with Target Price 34.60
Stock For June TTOO..1.19..T2 Biosystems T2 Biosystems offers diagnosticians and medical labs a range of devices based on its T2 Magnetic Resonance Tech to quickly Diagnose a Variety Of Septic Illnesses Company's technology enables blood tests results in a matter of hours..compared to the current 1 to 5 days currently taken by medical labs.. First quarter top-line Revenue grew 173% year over year to 7 million 345% year over year increase in product Revenue to 4.7 million Return on Equity in 2 years projected to be 7,300% Analysts Raised to Buy Price Target 3.50 TipRanks Strong Buy Target price 2.83
With A Name Like This You Know It Will Be A Winner Raised To Outperform HOWL..12.79..Werewolf Therapeutics..Innovative Biopharm pioneering the development of therapeutics to stimulate the body's immune system for treatment of cancer Return on Equity 74% Incredible FLOAT of 482K TipRanks Strong Buy with Target Price 24.67
Just Maybe From Bear To Bull ONCT..5.14..Oncternal Therapeutics Progress on its Cancer Drug Cirmtuzumab Phase 1/2 Investigational monoclonal antibody to treat patients with B-Cell Lymphoid Malignancies Considered Significantly Undervalues Float 44 million Forecast To Grow 52% compared to US Industry Average of 14% Walletinvestor Buy with one year forecast 11.30..Five year forecast 35.00 TipRanks Strong Buy 15.50
Save This Penny FDBL...0130..Friendable Cutting edge mobile app connecting fans to their favorite celebrity or artist. Fan Pass very popular Friendable to launch v2 release of its Fan Pass Livesteam Artist Platform in June Starting in 2021 Artist Events Grew 191% Reported an increase of 1200% to their Live Artist channel 65% increase in Revenue 401K compared to 242 in 2019 A Walletinvestor Buy with one year forecast of .032
VYGVF..19.08..VoyagerDigital Crypto Asset Broker Substantial Revenue GrowthQ3 Revenue 60.44 million compared to 281K a year go Record Revenue 60 million 50% Margin..Generating Operating profit of 30 million Walletinvestor High Recommendation..One year Forecast 30.79...Five year Forecast 81.15 TipRanks Strong Buy With Target Price 33.59
From Big Bear To Future Bull? A TipRanks Highlighted Bargain CHRS..Coherus Biosciences..12.95 Developes and manufactures biosimilar drugs..These are biological medicines designed to be similar in function to popular prescribed medications.. Approved Product Udenyca biosimilar to Neulasta which stimulates production of white blood cells Float 62 million Currently Trading Very Low Growth has been faster 64% than US Industry Average of 17% TipRanks Strong Buy Target price 22.00
USWS..Still at nice low entry considering future possibilities.. UCLE..Rose some to .50..Very low volume..But six months from now .50 will be in rear view mirror TONR..Dropped 34% yesterday to .0021 PHRRF..Down 19% .2499 despite early morning good news
Up 60% pre-market NBRV..2.37..Nabriva Therapeutics Just received positive results from Phse 3 Trial of Lefamulin..semi-synthetic pleuromutilin antibiotic systemic administration in humans Float 35 million Revenue forecast to grow 125% per year TipRanks Moderate Buy Target Price 6.00
News Before Opening Bell ADCT..20.71 Camidanlubab Tesirine shows anti-tumoral activity in Hodgkin Lymphoma ADC Therapeutics Bio-Tech leading the development of novel antibody drug treats hematological malignancies and solid tumors Float 27 million TipRanks Moderate Buy Target price 54.00
